Paeds Vivas · acute-care-resuscitation-and-toxicology
Humane restraint and behavioural support in emergency care — branching viva
A branching cross-table viva on the management of a nine-year-old boy with autism and intellectual disability brought to the emergency department in acute behavioural disturbance. The candidate is taken through ensuring safety, recognising autistic meltdown, treating reversible medical causes, leading verbal and environmental de-escalation, the oral-first pharmacological approach, escalation to parenteral rapid tranquillisation with cautions, restraint as a last resort, and the post-event debrief and safeguarding review. Designed to probe the why, the corners and the law.
On this page
Study tools
Target exams
Viva: branching structured oral
Stimulus. A nine-year-old boy with autism spectrum disorder and intellectual disability is brought to the emergency department in acute behavioural disturbance after a long wait in a noisy waiting room. He is throwing chairs.
[1]Stage 1: The first 60 seconds
Examiner. You are the consultant on. The triage nurse calls you to the cubicle. Walk me through your first 60 seconds.
[1]Model answer. I ensure the safety of the staff, the child and others first. I clear the cubicle of other patients and of hazards, I ask for the chairs to be moved out of reach, I confirm the exit is clear, and I call for senior nursing help and a second clinician. I name a team leader (me or a delegate), assign roles, and ask the parents to step back to a safe distance but to stay close because they will be central to the de-escalation. I do not approach the child yet. [1]
Examiner probe. Why not approach?
[1]Model answer. Because approaching an autistic child in meltdown head-on, with multiple staff, in a noisy cubicle, reliably worsens the trajectory. The first intervention is environmental: reduce the noise, reduce the light, clear the space, and bring in people the child trusts. I am preparing the conditions for de-escalation, not confronting the behaviour. [6]
References7ShowHide
- [1]Hilt RJ, Woodward TA Agitation treatment for pediatric emergency patients Journal of the American Academy of Child and Adolescent Psychiatry, 2008.PMID 18216715
- [3]Bourke EM, Borland ML, Kochar A, et al. Pharmacological emergency management of agitation in children and young people: protocol for a randomised controlled trial of oral medication (PEAChY-O) BMJ Open, 2023.PMID 36997250
- [4]Bourke EM, Kochar A, Shellshear D, et al. PEAChY-O: Pharmacological Emergency Management of Agitation in Children and Young People: A Randomized Controlled Trial of Oral Medication Annals of Emergency Medicine, 2025.PMID 39955661
- [7]Malashock HR, Yeung C, Roberts AR, et al. Pediatric Methamphetamine Toxicity: Clinical Manifestations and Therapeutic Use of Antipsychotics-One Institution's Experience Journal of Medical Toxicology, 2021.PMID 33442836
- [6]Bourke EM, Say DF, Carison A, et al. Emergency mental health presentations in children with autism spectrum disorder and attention deficit hyperactivity disorder Journal of Paediatrics and Child Health, 2021.PMID 33963626
- [8]Hilt RJ Editorial: Best Practices in Child Antipsychotic Use Monitoring Journal of the American Academy of Child and Adolescent Psychiatry, 2021.PMID 33176169
- [11]Menard ML, Thümmler S, Giannitelli M, et al. Incidence of adverse events in antipsychotic-naive children and adolescents treated with antipsychotic drugs: Results of a multicenter naturalistic study (ETAPE) European Neuropsychopharmacology, 2019.PMID 31699516